| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human BH3-interacting domain death agonist |
|---|
| Description | 1-195aa; Full Length. MW: 38kD. Purity >90% as determined by SDS-PAGE. The major proteolytic product p15 BID allows the release of cytochrome c. Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2. 1 Publication |
|---|
| Size | 0.01 mg (E-Coli), 0.05 mg (E-Coli), 0.1 mg (E-Coli), 0.2 mg (E-Coli), 0.05 mg (Yeast) |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [p22 BID; BID] |
|---|
| Gene, Accession, CAS # | BID, Gene ID: 637, Accession: NP_001187.1 |
|---|
| Catalog # | MBS949782 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human BH3-interacting domain death agonist from MYBIOSOURCE INC. |
|---|
| Product Specific References | BIDa novel BH3 domain-only death agonist.Wang K., Yin X.-M., Chao D.T., Milliman C.L., Korsmeyer S.J.Genes Dev. 10:2859-2869(1996) |
|---|
| 产品资料 |
|
|